UNSPSC 51281666: Spectinomycin dihydrochloride

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 296JEI210Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, but more generally known as spectinomycin dihydrochloride, which bears US NIH Compound Identifier 2021.

European Medicines Agency schedules spectinomycin dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG. Most nations, for tariff purposes, schedule spectinomycin dihydrochloride under HS 29419000. SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.CL.CL.

UNSPSC 51281666 Spectinomycin dihydrochloride is a Commodity code that does not align with the recent state and local contract opportunities tagged under it. The code nominally addresses a specific antibiotic pharmaceutical, yet the recent solicitations captured under this code—naloxone procurement, therapeutic pharmacy initiatives, medical and first aid supplies, and generic multi-source pharmaceuticals—span a broad range of health-related products and services that fall outside the narrow scope of a single chemical compound. The mismatch between the code's specificity and the diversity of the opportunities suggests either that the code is being applied inconsistently in state and local procurement systems or that it serves as a catch-all for pharmaceutical and health-supply categories. State and local governments issuing under this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), indicating that procurement authority is distributed across traditional departmental lines and specialized purchasing vehicles.

Recent activity shows geographic concentration in Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023); the City of Tampa's IFB for medical and first aid supplies for the Fire Department Rescue Division, valued at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises (due March 13, 2026); the Texas Health and Human Services Commission's RFI soliciting vendor capabilities for a direct-to-manufacturer pharmaceutical program (due April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products across participating state and local facilities, with proposals due March 26, 2026. The code shows little relevant recent activity when evaluated against its nominal scope; procurement under it appears to track general pharmaceutical, health-supply, and medical-equipment acquisitions rather than spectinomycin dihydrochloride specifically.